DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of MXN 411.87 billion. The enterprise value is 401.40 billion.

Market Cap	411.87B
Enterprise Value	401.40B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	384.86M
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.09%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	97.10%
Float	383.95M

Valuation Ratios

The trailing PE ratio is 27.36 and the forward PE ratio is 24.16.

PE Ratio	27.36
Forward PE	24.16
PS Ratio	4.91
PB Ratio	8.33
P/TBV Ratio	8.63
P/FCF Ratio	21.24
P/OCF Ratio	15.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.27, with an EV/FCF ratio of 20.70.

EV / Earnings	26.66
EV / Sales	4.95
EV / EBITDA	19.27
EV / EBIT	25.33
EV / FCF	20.70

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio	1.88
Quick Ratio	1.53
Debt / Equity	0.51
Debt / EBITDA	1.17
Debt / FCF	1.30
Interest Coverage	49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE)	34.50%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	33.98%
Return on Capital Employed (ROCE)	21.72%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.60M
Profits Per Employee	1.36M
Employee Count	11,050
Asset Turnover	0.73
Inventory Turnover	3.18

Taxes

In the past 12 months, DexCom has paid 4.54 billion in taxes.

Income Tax	4.54B
Effective Tax Rate	23.16%

Stock Price Statistics

The stock price has decreased by -32.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.37%
50-Day Moving Average	1,265.51
200-Day Moving Average	1,803.17
Relative Strength Index (RSI)	47.55
Average Volume (20 Days)	6,149

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, DexCom had revenue of MXN 83.93 billion and earned 15.06 billion in profits. Earnings per share was 37.62.

Revenue	83.93B
Gross Profit	50.44B
Operating Income	16.42B
Pretax Income	19.59B
Net Income	15.06B
EBITDA	20.95B
EBIT	16.42B
Earnings Per Share (EPS)	37.62

Balance Sheet

The company has 35.98 billion in cash and 25.14 billion in debt, giving a net cash position of 10.84 billion.

Cash & Cash Equivalents	35.98B
Total Debt	25.14B
Net Cash	10.84B
Net Cash Per Share	n/a
Equity (Book Value)	49.44B
Book Value Per Share	128.47
Working Capital	34.04B

Cash Flow

In the last 12 months, operating cash flow was 25.94 billion and capital expenditures -6.54 billion, giving a free cash flow of 19.39 billion.

Operating Cash Flow	25.94B
Capital Expenditures	-6.54B
Depreciation & Amortization	4.38B
Net Borrowing	-20.99B
Free Cash Flow	19.39B
FCF Per Share	n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin	60.10%
Operating Margin	19.56%
Pretax Margin	23.35%
Profit Margin	17.94%
EBITDA Margin	24.96%
EBIT Margin	19.56%
FCF Margin	23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.75%
Shareholder Yield	1.75%
Earnings Yield	3.66%
FCF Yield	4.71%

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score	7.06
Piotroski F-Score	6